Global Whole Genome Sequencing Market Research Report with Opportunities and Strategies to Boost Growth- COVID-19 Impact and Recovery

Whole exome sequencing is a technology that caused complete DNA sequence of any organism’s genome at the single time through the help of various laboratory processes. In the future of personalized medicine, whole genome sequence will play an important role in guiding the therapeutic intervention. Currently, it is being widely used for the identification and the determination of genetic variants causing various diseases such as Miller syndrome and Alzheimer’s disease.
Based on the Whole Genome Sequencing market development status, competitive landscape and development model in different regions of the world, this report is dedicated to providing niche markets, potential risks and comprehensive competitive strategy analysis in different fields. From the competitive advantages of different types of products and services, the development opportunities and consumption characteristics and structure analysis of the downstream application fields are all analyzed in detail. To Boost Growth during the epidemic era, this report analyzes in detail for the potential risks and opportunities which can be focused on.

In Chapter 2.4 of the report, we share our perspectives for the impact of COVID-19 from the long and short term.
In chapter 3.4, we provide the influence of the crisis on the industry chain, especially for marketing channels.
In chapters 8-13, we update the timely industry economic revitalization plan of the country-wise government.

Key players in the global Whole Genome Sequencing market covered in Chapter 5:
10x Genomics
GENEWIZ
BGI (Complete Genomics)
Agilent Technologies
Eurofins Scientific Group
Macrogen
Oxford Nanopore Technologies
Illumina
Novogene
PacBio
QIAGEN
Berry Genomics
PerkinElmer
Roche

In Chapter 6, on the basis of types, the Whole Genome Sequencing market from 2015 to 2025 is primarily split into:
Second-generation Sequencing
Third-generation Sequencing

In Chapter 7, on the basis of applications, the Whole Genome Sequencing market from 2015 to 2025 covers:
Diagnostics
Drug Discovery and Development
Personalized Medicine
Other Applications (Agriculture, Animal Research, etc.)

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 8-13:
North America (Covered in Chapter 9)
United States
Canada
Mexico
Europe (Covered in Chapter 10)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 11)
China
Japan
South Korea
Australia
India
South America (Covered in Chapter 12)
Brazil
Argentina
Columbia
Middle East and Africa (Covered in Chapter 13)
UAE
Egypt
South Africa

Years considered for this report:


Historical Years:

2015-2019

Base Year:

2019

Estimated Year:

2020

Forecast Period:

2020-2025

Frequently Asked Questions



This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.

  • By product type
  • By End User/Applications
  • By Technology
  • By Region

The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.

Please Select a Format

market Reports market Reports